Sinovac Biotech

Chinese biopharm company

SVA Nasdaq ISIN AGP8696W1045 SEC CIK 1084201 LEI 529900DOOGH8WKB2WL85
Follow Sinovac Biotech Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$5B$0$5B$10B$15B$20BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$386M−$198.8M
FY24$361.4M$40.7M
FY23$470.2M−$13.5M
FY22$1.5B$14.5M
FY21$19.4B$8.1B
FY20$510.6M$110.4M
FY19$246.1M$44.9M
FY18$229.7M$21.8M
FY17$174.3M$25.8M
FY16$72.4M−$596K
FY15$67.4M−$1.4M
FY14$62.9M−$1.5M
FY13$71.8M$7.4M
FY12$49.2M−$18.7M
FY11$56.8M−$844.7K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2567.9%−127%−51.5%
FY2461.1%−139.9%11.3%
FY2368.8%−151.9%−2.9%
FY2255.3%−34.5%1%
FY2194.9%91%41.9%
FY2086.8%42.2%21.6%
FY1986.8%27.9%18.3%
FY1889.2%19.7%9.5%
FY1788.4%26%14.8%
FY1669.1%0.7%−0.8%
FY1572.7%5.5%−2.1%
FY1475.4%3%−2.4%
FY1371.4%13.9%10.4%
FY1261.2%−43%−38.1%
FY1162.8%5.9%−1.5%
Free cash flowOperating cash flow minus capital expenditure
−$5B$0$5B$10B$15BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$561.1M
FY24−$152.9M
FY23−$17.5M
FY22−$1.1B
FY21$14.7B
FY20$351.8M
FY19$28.4M
FY18$2.3M
FY17$47.8M
FY16−$26.6M
FY15−$1.1M
FY14−$21M
FY13$443K
FY12−$32.4M
FY11−$1.5M
Returned to shareholdersDividends paid and shares bought back
$0$1B$2B$3B$4BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividends
FY25$3.5B
FY24$947M
FY23$328.1M
FY22$247.4M
FY21$1.9B
FY20$0
FY19$0
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12$802.2K
FY11$5.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Sinovac Biotech
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearSinovac BiotechHealthcare median
FY25−51.5%−30.6%
FY2411.3%−47%
FY23−2.9%−58%
FY221%−80.4%
FY2141.9%−71.9%
FY2021.6%−62.2%
FY1918.3%−46.3%
FY189.5%−49.6%
FY1714.8%−45.9%
FY16−0.8%−36%
FY15−2.1%−38.4%
FY14−2.4%−35.5%
FY1310.4%−37.1%
FY12−38.1%−29.1%
FY11−1.5%−27.9%